Proliferative activity, angiogenesis, and necrosis in peripheral nerve sheath tumors: A quantitative evaluation for prognosis

Modern Pathology

Volumn 9, Issue 12, 1996, Pages 1108-1117

  Miracco, Clelia ^a   Montesco, Maria Cristina ^b   Santopietro, Rosa ^a   Spina, Donatella ^a   D'Amore, Emanuele S G ^b   Tosi, Piero ^a   Ninfo, Vito ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

AgNOR; Apoptosis; Mitosis; Morphometry; Neovascularization; Prognosis

Indexed keywords

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CHROMOSOME NOR; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NECROSIS; NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; PERIPHERAL NERVE TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; APOPTOSIS; CELL COUNT; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MITOSIS; NECROSIS; NEOVASCULARIZATION, PATHOLOGIC; NEURILEMMOMA; NEUROFIBROMA; NUCLEOLUS ORGANIZER REGION; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PROGNOSIS; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 0030469454     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hashimoto H, Daimaru Y, Takeshita S, Tsuneyoshi M, Enjoji M: Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer 70:2816, 1992
2. Enzinger FM, Weiss SW: Malignant tumors of the peripheral nerves. In Soft Tissue Tumors, edited by Gay SM, Ed 3, p 889. St. Louis, Mosby, 1995
3. Baak JPA: Mitosis counting in tumors. Hum Pathol 21:683, 1990
4. Hilsenbeck SG, Allred DG: Improved methods of estimating mitotic activity in solid tumors. Hum Pathol 23:601, 1992
5. Staunton MJ, Gaffney EF: Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol 103:300, 1995
6. Weibel ER: Synopsis of coherent test systems (Appendix 3). In Stereological Methods, Vol 1: Practical Methods for Biological Morphometry, edited by Weibel ER. London, Academic, 1979
7. Wilkinson L: Systat: The system for statistics. Evanston, IL, Systat, 1989
8. Morrison DF: Multivariate statistical methods. New York, McGraw-Hill, 1976.
9. Markhede G, Angervall L, Stener B: A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer 49:1721, 1982
10. Ueda T, Aosaza K, Tsujimoto M, et al.: Multivariate analysis for clinical prognostic factors in 163 patients with soft tissue sarcoma. Cancer 62:1444, 1988
11. Alvegard TA, Berg NO, Baldetorp BO, et al.: Cellular DNA content and prognosis of high-grade soft tissue sarcoma: The Scandinavian sarcoma group experience. J Clin Oncol 8:538, 1990
12. Becker RL, Venzon UMCD, Lack EE, et al.: Cytometry and morphometry of malignant fibrous histiocytoma of the extremities. Prediction of metastasis and mortality. Am J Surg Pathol 15:957, 1991
13. Tsokos M, Webber BL, Parham DM, et al.: Rhabdomyosarcoma: A new classification scheme related to prognosis. Arch Pathol Lab Med 116:847, 1992
14. van Unnik JAM, Coindre JM, Contesso C, et al.: Grading of soft tissue sarcomas: Experience of the EORTc Soft Tissue and Bone Sarcoma Group. Eur J Cancer 29A:2089, 1993
15. Tomita Y, Aosaza K, Myoui A, et al.: Histologic grading in soft-tissue sarcomas. An analysis of 194 cases including Ag-NOR count and mast-cell count. Int J Cancer 54:194, 1993
16. Remmelink M, Salmon I, Petein M, et al.: Determination of DNA ploidy, nuclear size and proliferative activity by means of the computer-assisted image analysis of Feulgen-stained nuclei in 68 soft tissue tumors of adults. Hum Pathol 25:694, 1994
17. Costa J, Wesley RA, Glastein E, Rosenberg SA: The grading of soft tissue sarcomas. Results of a clinicopathologic correlation in a series of 163 cases. Cancer 53:530, 1984
18. Trojani M, Contesso G, Coindre JM, et al.: Soft-tissue sarcomas of adults: Study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 33:37, 1984
19. Rooser BO, Attewell R, Berg NO, Rydholm A: Prognostication in soft-tissue sarcomas. A model with four risk factors. Cancer 61:817, 1988
20. Tsujimoto M, Aosaza K, Ueda T, et al.: Multivariate analysis for histologic prognostic factors in soft-tissue sarcomas. Cancer 62:994, 1988
21. Kulander BG, Polissar L, Yang CY, Woods JS: Grading of soft tissue sarcomas. Necrosis as a determinant of survival. Mod Pathol 2:205, 1989
22. Lack EE, Steinberg SM, White DE, et al: Extremity soft-tissue sarcomas: Analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas. J Surg Oncol 41:263, 1983
23. Mandard AM, Petiot JF, Marnay J, et al.: Prognostic factors in soft-tissue sarcomas. A multivariate analysis of 109 cases. Cancer 63:1437, 1989
24. Norris HJ: Mitosis counting. Hum Pathol 7:483, 1976
25. Graem N, Helweg-Larsen K: Mitotic activity and delay in fixation of tumor tissue. Acta Pathol Microbiol Immunol Scand A 87:375, 1989
26. Donhuijsen K, Schmidt U, Hirche H, van Beuningen D, Budach V: Changes in mitotic rate and cell cycle fractions caused by delayed fixation. Hum Pathol 21:709, 1990
27. Kerr JFR, Searle I, Harmon BV, Bishop CJ: Apoptosis. In Perspectives in Mammalian Cell Death, edited by Potten CS, p 93. Oxford, Oxford University Press, 1987
28. Wyllie AH: Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metastasis Rev 11:95, 1992
29. Stephens LC, Hunter NR, Ang KK, Milas L, Meyn RE: Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat Res 135:75, 1993
30. Treré D: Critical analysis of the methods commonly employed in the assessment of cell proliferation: Advantages of the NOR silver-staining technique in routine cyto-histopathology. Anal Cell Pathol 5:191, 1993
31. Derenzini M, Nardi F, Farabegoli F, et al.: Distribution of silver-stained interphase nucleolar organizer regions as a parameter to distinguish neoplastic from non-neoplastic reactive cells in human effusions. Acta Cytol 33:491, 1989
32. Ruschoff J, Plate KH, Contractor H, et al.: Evaluation of nucleolus organizer regions (NORs) by automatic image analysis: A contribution to standardization. J Pathol 161:113, 1990
33. Yekeler H, Erel O, Yumbul AZ, et al.: A sensitive staining method for NORs. J Pathol 175:449, 1995
34. Kuratsu S, Aozasa K, Myoui A, et al.: Prognostic significance of argyrophilic nucleolar organizer staining in soft-tissue sarcomas. Int J Cancer 48:211, 1991
35. Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:59, 1989
36. Folkman J, Shing T: Angiogenesis. J Biol Chem 267:10931, 1992
37. Bosari S, Lee AKC, De Lellis RA, et al.: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755, 1992
38. Weidner N, Folkman J, Pozza F, et al.: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875, 1992
39. DeYoung BR, Wick MR, Fitzgibbon JF et al.: CD31: An immunospecific marker for endothelial differentiation in human neoplasms. Appl Immunohistochem 1:97, 1993
40. Miettinen M, Lindenmayer AE, Chaubal A: Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens. Evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7:82, 1994
41. Svirastava A, Laidler P, Davies RP, Horgan K, Hughes LE: The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.00-mm-thick) skin melanoma. A quantitative histologic study. Am J Pathol 133:419, 1988
42. Barnhill RL, Busam KJ, Berwick M, et al.: Tumour vascularity is not a prognostic factor for cutaneous melanoma. Lancet 344:1237, 1994
43. Coindre JM, Trojani M, Contesso G, et al.: Reproducibility of a histopatholologic grading system for adult soft tissue sarcoma. Cancer 58:306, 1986